Compare ETV & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Current Price
| Metric | ETV | AORT |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2005 | 1996 |
| Metric | ETV | AORT |
|---|---|---|
| Price | $15.41 | $26.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.40 |
| AVG Volume (30 Days) | 148.4K | ★ 719.0K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $13.13 | $19.16 |
| 52 Week High | $15.33 | $48.25 |
| Indicator | ETV | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 48.44 |
| Support Level | $14.22 | $25.79 |
| Resistance Level | $15.32 | $28.29 |
| Average True Range (ATR) | 0.16 | 1.12 |
| MACD | 0.01 | -0.32 |
| Stochastic Oscillator | 88.37 | 16.75 |
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.